Since 1998, the Respiratory Research Center, formerly the Rehabilitation Clinical Trials Center (RCTC), at The Lundquist Institute has conducted cutting-edge clinical and translational research to improve the lives of patients with chronic lung diseases.

Our UCLA-affiliated research team, headed by Medical Directors Drs. Richard Casaburi and William Stringer, has pioneered new diagnostics, medications, devices and therapies to improve breathing, enhance exercise tolerance, promote physical activity and reduce exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD).

Our center has published over 450 original research articles in leading medical journals on respiratory physiology and medicine, cardiopulmonary exercise testing, pulmonary rehabilitation and COPD.

Our research team is dedicated to improving exercise tolerance, physical activity and quality of life of patients living with chronic respiratory diseases.

Research Specialties

  • Asthma

    Asthma is a condition in which your airways narrow and swell and may produce extra mucus. This can make breathing difficult and trigger coughing, a whistling sound (wheezing)

  • Exercise Training and Rehabilitation

    Pulmonary rehabilitation (PR) is a supervised medical program that helps people who have lung diseases live and breathe better.

  • Long Haul COVID

    The CDC uses the term “Long Haul COVID” to describe post-COVID health issues that persist more than four weeks after a person is first infected

  • Unexplained Dyspnea & Exercise Intolerance

    Shortness-of-breath, or Dyspnea, is a common symptom that causes exercise limitation or “intolerance”. Breathlessness during exercise is often

  • Muscle Weakness

    There are many reasons why individuals may lose strength, but in many patients with chronic heart, lung or kidney diseases the loss of muscle mass and strength is faster than normal.